Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 3/20 | 0.34 |
| ▸ | ACHE | P22303 | 3/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1338718 | 0.89 | LMNA (0.43) | LMNABCHEACHEPTGS2EPHX1 | |
| SCHEMBL18253207 | 0.82 | EPHX1 (0.44) | LMNABCHEACHEPTGS2EPHX1 | |
| SCHEMBL27818932 | 0.80 | PTGS2 (0.50) | LMNABCHEACHEPTGS2SLC6A2 | |
| SCHEMBL8750550 | 0.80 | FFAR1 (0.39) | LMNABCHEACHEPTGS2 | |
| SCHEMBL10230188 | 0.78 | CHRM2 (0.39) | LMNABCHEACHEPTGS2SLC6A2 | |
| SCHEMBL18722667 | 0.78 | SLC6A2 (0.50) | LMNASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL21949745 | 0.78 | TDP1 (0.45) | LMNAACHEEPHX1 | |
| SCHEMBL13662055 | 0.78 | TSHR (0.47) | LMNA | |
| SCHEMBL2219321 | 0.78 | ESR1 (0.50) | LMNASLC6A2SLC6A3 | |
| SCHEMBL1151204 | 0.78 | ALDH1A1 (0.42) | LMNABCHEACHEPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6420418-B1 | INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE | MERCK & CO., INC. | 2002-07-16 | — | — | US | disclosed |
| WO-2001012183-A1 | HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS | MERCK & CO., INC. (US) | 2001-02-22 | — | — | WO | disclosed |